Watching MIRA Pharmaceuticals; Zacks Small-Cap Research Report Being Circulated, Gives Co $16.50 Price Valuation
Portfolio Pulse from Benzinga Newsdesk
Zacks Small-Cap Research has released a report on MIRA Pharmaceuticals, giving the company a price valuation of $16.50. This report is currently being circulated.
July 22, 2024 | 3:18 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Zacks Small-Cap Research has issued a report valuing MIRA Pharmaceuticals at $16.50. This valuation is currently being circulated and could influence investor sentiment.
The valuation report from Zacks Small-Cap Research is likely to positively influence investor sentiment towards MIRA Pharmaceuticals, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100